Total Current Assets Total Assets Related and Nonrelated Parties [Axis] Total Current Liabilities Total Liabilities Total Stockholders’ Deficit Balance Balance Stockholders’ deficit Total Liabilities and Stockholders’ Deficit Total operating expenses Operating expenses Net loss from operations Total other income (expense) Net income (loss) before taxes Net income (loss) Net income (loss) Net income Balance (in Shares) Balance (in Shares) Equity Components [Axis] Net Cash Used in Operating Activities Net cash used in operating activities Net Cash Provided by Financing Activities Net change in cash Cash, beginning of period Cash, end of period Cash Organization and Nature of Operations [Abstract] Summary of Significant Accounting Policies [Abstract] Schedule of Basic and Diluted Income (Loss) Per Share [Abstract] Antidilutive Securities [Axis] Notes Payable and Convertible Notes Payable [Abstract] Schedule of Convertible Notes Payable [Abstract] Balance Balance Derivative and Warrant liabilities [Abstract] Measurement Input Type [Axis] Statistical Measurement [Axis] Balance Balance Derivative liability Balance Balance Warrant liability Fair Value Hierarchy and NAV [Axis] Warrants [Abstract] Number of Warrants, Outstanding Ending Number of Warrants, Outstanding Ending Weighted Average Exercise Price, Outstanding Ending Weighted Average Exercise Price, Outstanding Ending Stockholders’ Equity [Abstract] Commitments and Contingencies [Abstract] Tranche [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Related Party Transactions [Abstract] Short-Term Debt, Type [Axis] Due to related party Due to related party Other Investment [Abstract] Segment Report [Abstract] Subsequent Events [Abstract] Assets Current Assets Inventory Prepaid expenses Deferred offering cost Note receivable Other investment Intangible assets, net of accumulated Liabilities and Stockholders’ Deficit Current Liabilities Bank overdraft Accounts payable and accrued liabilities Notes payable Convertible notes payable, net Stockholders’ Deficit Preferred stock: 7,000,000 authorized; $0.001 par value, 7,000,000 shares issued and outstanding Preferred stock, authorized (in Shares) Preferred stock, shares authorized Preferred stock, par value (in Dollars per share) Preferred stock, shares issued (in Shares) Preferred stock, shares issued Preferred stock, shares outstanding (in Shares) Preferred stock, shares outstanding Common stock: 1,250,000,000 authorized; $0.001 par value, 167,166,897 and 162,569,807 shares issued and outstanding, respectively Common stock, valued Common stock, shares authorized (in Shares) Common stock, shares authorized Common stock, par value (in Dollars per share) Common stock, shares issued (in Shares) Common stock, shares issued Common stock, shares outstanding (in Shares) Common stock, shares outstanding Additional paid in capital Accumulated deficit Revenues Operating expenses General and administration expenses Research and development Research and development expenses Other income (expense) Interest income Interest income Other income Change in fair value of derivative liability Change in fair value of derivative liability (Gain) on change in fair value of the derivative Gain on equity securities exchange Gain on equity securities exchange Unrealized gain on marketable security Unrealized gain on marketable security Unrealized gain on other investment (in Dollars) Basic income (loss) per common share (in Dollars per share) Basic - Net income (loss) (in Dollars per share) Diluted income (loss) per common share (in Dollars per share) Diluted - Net income (loss) (in Dollars per share) Weighted average number of common shares outstanding, basic (in Shares) Weighted average common shares outstanding Weighted average number of common shares outstanding, diluted (in Shares) Diluted Common stock issued for settlement expenses Common stock market value Common stock issued for settlement expenses (in Shares) Issuance of common stock shares (in Shares) Reversal of previously recognized stock-based compensation Common stock issued for services Value of common stock for services (in Dollars) Common stock issued for services (in Shares) Shares issued for services Cash Flows from Operating Activities: Adjustments to reconcile net income (loss) to net cash used in operating activities: Stock issued for services Stock issued for settlement of claims Reversal of previously recognized stock-based compensation Amortization of debt discount Amortization of debt discount Amortization of debt discount (in Dollars) Change in fair value of warrant liability Change in fair value of warrant liability Loss on change in fair value of the derivative Changes in operating assets and liabilities: Accounts payable and accrued liabilities Cash Flows from Financing Activities: Proceeds from related party Proceeds from convertible notes payable - net Cash purchase on Convertible debt (in Dollars) Supplemental cash flow information: Cash paid for interest Cash paid for taxes Supplemental disclosure of non-cash financing activity: Recognition of warrant liability Exchange of 2,500,000 shares of LMMY common stock in exchange for MAJI preferred shares Interest expense Convertible notes of interest expense (in Dollars) Income tax benefit Prepaid expenses Deferred offering cost Repayments to related party Repaid of related party Repayment the bank overdraft Related Party Related Party [Member] Convertible Preferred Stock Common Stock Common Stock [Member] Additional Paid in Capital Accumulated Deficit Organization and Nature of Operations Summary of Significant Accounting Policies Schedule of Basic and Diluted Income (Loss) Per Share Numerator: Net income (loss) (in Dollars) Interest on convertible debts (in Dollars) Net income (loss) - diluted (in Dollars) Denominator: Effect of dilutive shares Convertible notes Preferred stock Net income per common share: Schedule of Common Stock Equivalents, Which are Potentially Dilutive Equity Securities Potentially dilutive equity securities Notes Payable and Convertible Notes Payable Schedule of Convertible Notes Payable Guaranteed interest recorded to convertible note payable Original issue debt discount (“OID”) Derivative and Warrant liabilities Schedule of Estimated Fair Values of the Liabilities Measured on a Recurring Basis Derivative Liability, Measurement Input Warrant, Measurement Input Schedule of Changes in Derivative Liabilities and Warrant Liabilities Addition of new derivatives recognized as debt discount - warrant Estimated fair value Warrants Schedule of Activity of the Warrants Weighted Average Remaining Life (Years), Outstanding Ending Number of Warrants, Grant Weighted Average Exercise Price, Grant Weighted Average Remaining Life (Years), Grant Number of Warrants, Exercised Weighted Average Exercise Price, Exercised Weighted Average Remaining Life (Years), Exercised Number of Warrants, Cancelled Weighted Average Exercise Price, Cancelled Weighted Average Remaining Life (Years), Cancelled Number of Warrants, Exercisable Weighted Average Exercise Price, Exercisable Weighted Average Remaining Life (Years), Exercisable Stockholders’ Equity Commitments and Contingencies Schedule of Monthly Payment Paid Monthly Accrued Monthly Related party transactions Schedule of Due to Related Party Note payable Interest rate Other investment Schedule of Fair Value on a Recurring Basis and the Fair Value Hierarchy Investment in Exousia Bio, Inc.